{"id":11538,"date":"2022-03-08T14:37:28","date_gmt":"2022-03-08T13:37:28","guid":{"rendered":"https:\/\/pharmanutra.it\/a-new-technology-to-counter-iron-deficiency\/"},"modified":"2022-03-08T14:37:28","modified_gmt":"2022-03-08T13:37:28","slug":"a-new-technology-to-counter-iron-deficiency","status":"publish","type":"post","link":"https:\/\/www.pharmanutra.it\/en\/a-new-technology-to-counter-iron-deficiency\/","title":{"rendered":"A new technology to counter iron deficiency"},"content":{"rendered":"

Sucrosomial\u00ae iron is an innovative oral iron technology, in which ferric pyrophosphate (trivalent iron) is transported within a matrix of phospholipids and sucrose esters of fatty acids. This structure, called Sucrosome\u00ae, allows high absorption of iron and optimal gastrointestinal tolerability.<\/em><\/p>\n

Iron deficiency (ID) <\/u><\/strong><\/p>\n

Iron is an essential element for the body. It promotes the formation of hemoglobin and myoglobin, supports the immune system and normal cognitive function as well as supporting growth in children and adolescents.<\/p>\n

The causes that can lead to the increase in the need for iron are different, but, in all cases, it is necessary to restore the body\u2019s balance of this nutrient in order to facilitate certain normal physiological functions of our bodies.<\/p>\n

Iron deficiency (ID) is a condition characterized by a low level of this mineral in the body, that, if not recovered, leads to an anemic clinical condition. Iron deficiency anemia (IDA) occurs when the body is not able to satisfy a right hemoglobin production, which is pivotal to ensure the oxygenation of tissues and cells of the body.<\/p>\n

The main causes of ID are increased demand, reduced absorption, and increased loss of iron.<\/p>\n

In the picture below is shown the presence of ID on specific clinical conditions:<\/p>\n

\"\"<\/p>\n

Source: Susana G\u00f3mez-Ram\u00edrez et al., Sucrosomial\u00ae Iron: A New Generation Iron for Improving Oral Supplementation.<\/p>\n

World Health Organization (WHO) has defined the values of hemoglobin (Hb) as normal range at 14-18 g\/dL for men and 12-16 g\/dL for women; below these values, iron deficiency anemia is diagnosed. Other important markers to be considered for ID anemia are: ferritin, <\/em>a storage protein able to contain up to 4500 iron atoms, transferrin saturation (%TSAT)<\/em>, as this glycoprotein is able to transport iron to the tissues and body districts that use this mineral,<\/em> and sideremia<\/em>, which indicates the amount of iron bound to transferrin <\/em>in the bloodstream.<\/p>\n

Iron Deficiency itself, instead, doesn\u2019t always show hematological alterations; in fact, the hemoglobin level can be within the normal range, but the ferritin and the saturation of transferrin can be below. If the deficiency is not timely adjusted, it could develop in IDA.<\/p>\n

The common symptoms related with ID and IDA, are:<\/p>\n